ArticleCell transplantation

Salvage nintedanib plus low-dose ruxolitinib therapy for bronchiolitis obliterans syndrome refractory to calcineurin inhibitors and glucocorticoids after allogeneic transplantation.

Ya Luo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.